Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...
"Success is never owned, it's rented. And the rent is due every day." Keep raising the bar with readiness, not just for the here and now, but for tomorrow. Surhabi PokhriyalChief Digital Growth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results